Exothera vs ReiThera: CDMO Comparison
How does Exothera compare to ReiThera?
As of Mar 2026, Exothera: no FDA inspections on file, 4 EMA/MHRA GMP certificates. Signal Score 78.1. ReiThera: no FDA inspections on file, 4 EMA/MHRA GMP certificates. Signal Score 71.1. Counts are the established FDA, EMA and MHRA records on each profile. CDMOs cannot pay to change a score.
Side-by-side comparison of Exothera and ReiThera on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Frequently asked: Exothera vs ReiThera
How does Exothera compare to ReiThera?
On CDMO Signal's composite Signal Score, Exothera is 78/100 and ReiThera is 71/100; European coverage is 4 active EMA+MHRA certificates for Exothera vs 4 for ReiThera. Both are tracked in the CDMO Signal directory. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
How do Exothera and ReiThera compare on European GMP coverage?
Exothera holds 4 active EMA GMP certificates and 0 MHRA / UK certificates. ReiThera holds 4 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is more active in clinical-stage manufacturing — Exothera or ReiThera?
Exothera is matched to 0 ClinicalTrials.gov records as a manufacturing partner; ReiThera is matched to 1. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.
What does the Signal Score gap mean in practice?
Exothera carries a Signal Score of 78/100 and ReiThera carries 71/100 — a small lead for Exothera. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →